CJC-1295 (10mg)

CJC-1295, also known as Mod GRF 1-29, is a powerful synthetic analog of the endogenous Growth Hormone Releasing Hormone (GHRH). This 10mg formulation is engineered for researchers seeking to observe precise, pulsatile increases in plasma growth hormone levels. Unlike the DAC version, this "No DAC" variant has a shorter half-life, more closely mimicking the natural physiological peaks of growth hormone secretion.

Primary Mechanisms of Action:

• Rapid Pulsatile Release: Acts directly on the pituitary gland to stimulate a fast-acting secretion of growth hormone (GH), following the body's natural circadian rhythms.

• Cellular Homeostasis: Promotes protein synthesis and cellular repair mechanisms through the secondary elevation of Insulin-like Growth Factor 1 (IGF-1).

• Metabolic Efficiency: Enhances the mobilization of fatty acids for oxidation, supporting the development of lean tissue and systemic metabolic health.

• Neurological Recovery: Supports deep-stage sleep cycles, which are vital for neuro-regeneration and cognitive restoration.

The NuroSynthiX Purity Standard

At NuroSynthiX, we understand that research integrity requires molecular perfection. Our CJC-1295 (No DAC) 10mg vials are lyophilized for extreme stability and tested via HPLC to ensure a purity profile of ≥99%. This ensures that your laboratory data is consistent and free from the interference of synthetic byproducts.

FDA Compliance & Research Disclaimer

IMPORTANT: This product is intended for research and laboratory use only. It is not intended for human consumption or for the diagnosis, treatment, cure, or prevention of any disease.

The statements regarding CJC-1295 (No DAC) have not been evaluated by the Food and Drug Administration (FDA). This product is not an FDA-approved medication. NuroSynthiX strictly prohibits the use of its products for any purpose other than professional laboratory research. Any unauthorized application of this compound is strictly at the user's own risk.